4.5 Article

Segmental schwannomatosis: characteristics in 12 patients

Journal

ORPHANET JOURNAL OF RARE DISEASES
Volume 14, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13023-019-1176-4

Keywords

Segmental schwannomatosis; Neurofibromatosis; LZTR1 mutation

Ask authors/readers for more resources

Background Segmental schwannomatosis is characterized by multiple schwannomas affecting one-limb or less than 5 contiguous segments of spine. Its characteristics are not well described in the literature. Our objective was to better describe the demographic and clinical characteristics of this condition. Methods This was a retrospective, bi-center study conducted in two French expert centers for neurofibromatosis and schwannomatosis. The clinical, radiographic, pathological and molecular aspects were extracted from patients' clinical records. Results Twelve patients with segmental schwannomatosis were identified. Eight were female and 4 were male. The median age at initial symptom was 29 years (range: 6-60 years) and the median age at diagnosis was 34.5 years (range: 13-65 years). Pain was the initial symptom for the majority of patients (7 of 12). The number of tumors was variable with six patients having more than 10 tumors. Peripheral distribution was seen in all patients. Quality of life could be impaired (median Dermatology Life Quality Index score was 4.5 (range: 2-13). The median duration of follow up was 3 years (range: 1-26). Chronic pain was the main complication (9 of 12 patients). Surgical intervention to control chronic pain was performed for 9 patients of whom 5 experienced recurrence of tumors. Molecular investigations revealed heterozygous LZTR1 variants in 3 of 9 patients. Conclusion Segmental schwannomatosis is a rare condition that may start early in life and often remains undiagnosed for many years. Pain is the main symptom and consequently could impair the quality of life. Surgery seems to be effective, but recurrences are frequent. Some patients carried heterozygous LZTR1 variants. Further studies are needed to better understand this rare condition.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients

Samiya Abi Jaoude, Matthieu Peyre, Vincent Degos, Stephane Goutagny, Beatrice Parfait, Michel Kalamarides

Summary: In this study, the authors analyzed predictors of rapid meningioma growth in NF2 patients using a dedicated predicting model. They found that larger tumor volume at diagnosis, presence of peritumoral edema, absence of calcifications, and hyperintense or isointense signal on T2-weighted MRI were significantly associated with rapid tumor growth. The authors' multivariate model showed a similar predictive ability to the AIMSS score in this NF2 cohort.

JOURNAL OF NEUROSURGERY (2021)

Article Gastroenterology & Hepatology

Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes

Thierry Poynard, Valerie Paradis, Jimmy Mullaert, Olivier Deckmyn, Nathalie Gault, Estelle Marcault, Pauline Manchon, Nassima Si Mohammed, Beatrice Parfait, Mark Ibberson, Jean-Francois Gautier, Christian Boitard, Sebastien Czernichow, Etienne Larger, Fabienne Drane, Jean Marie Castille, Valentina Peta, Angelique Brzustowski, Benoit Terris, Anais Vallet-Pichard, Dominique Roulot, Cedric Laouenan, Pierre Bedossa, Laurent Castera, Stanislas Pol, Dominique Valla

Summary: The study aimed to externally validate the performance of Nash-FibroTest panel in assessing the severity of fibrosis stages, NASH grades, and steatosis grades in patients with type 2 diabetes. The diagnostic performance of each component of the panel was found to be significant, providing non-invasive diagnosis of fibrosis stages, NASH grades, and steatosis grades from a single blood sample.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Article Infectious Diseases

Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study

Solen Kerneis, Caroline Elie, Jacques Fourgeaud, Laure Choupeaux, Severine Mercier Delarue, Marie-Laure Alby, Pierre Quentin, Juliette Pavie, Patricia Brazille, Marie Laure Nere, Marine Minier, Audrey Gabassi, Aurelien Gibaud, Sebastien Gauthier, Chrystel Leroy, Etienne Voirin-Mathieu, Claire Poyart, Michel Vidaud, Beatrice Parfait, Constance Delaugerre, Jean-Marc Treluyer, Jerome LeGoff

Summary: This study aimed to evaluate the diagnostic accuracy of nasopharyngeal antigen rapid testing and saliva nucleic acid testing for detecting SARS-CoV-2 in ambulatory care settings. The findings suggest that the diagnostic accuracy of saliva nucleic acid testing and nasopharyngeal antigen testing is similar to that of nasopharyngeal nucleic acid testing, but adherence to specific saliva protocols is required.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

Letter Biochemistry & Molecular Biology

A French cohort for assessing COVID-19 vaccine responses in specific populations

Paul Loubet, Linda Wittkop, Eric Tartour, Beatrice Parfait, Benoit Barrou, Jean-Yves Blay, Maryvonne Hourmant, Marie Lachatre, David-Axel Laplaud, Martine Laville, Bruno Laviolle, Jean-Daniel Lelievre, Jacques Morel, Stephanie Nguyen, Jean-Philippe Spano, Benjamin Terrier, Anne Thiebaut, Jean-Francois Viallard, Francois Vrtovsnik, Xavier de Lamballerie, Odile Launay

NATURE MEDICINE (2021)

Article Oncology

Severe Phenotype in Patients with Large Deletions of NF1

Laurence Pacot, Dominique Vidaud, Audrey Sabbagh, Ingrid Laurendeau, Audrey Briand-Suleau, Audrey Coustier, Theodora Maillard, Cecile Barbance, Fanny Morice-Picard, Sabine Sigaudy, Olga O. Glazunova, Lena Damaj, Valerie Layet, Chloe Quelin, Brigitte Gilbert-Dussardier, Frederique Audic, Helene Dollfus, Anne-Marie Guerrot, James Lespinasse, Sophie Julia, Marie-Christine Vantyghem, Magali Drouard, Marilyn Lackmy, Bruno Leheup, Yves Alembik, Alexia Lemaire, Patrick Nitschke, Florence Petit, Anne Dieux Coeslier, Eugenie Mutez, Alain Taieb, Melanie Fradin, Yline Capri, Hala Nasser, Lyse Ruaud, Benjamin Dauriat, Sylvie Bourthoumieu, David Genevieve, Severine Audebert-Bellanger, Mathilde Nizon, Radka Stoeva, Geoffroy Hickman, Gael Nicolas, Juliette Mazereeuw-Hautier, Arnaud Jannic, Salah Ferkal, Beatrice Parfait, Michel Vidaud, Pierre Wolkenstein, Eric Pasmant

Summary: NF1 gene deletion is identified in 5-10% of NF1 patients, leading to a more severe phenotype characterized by cognitive impairments and various organic abnormalities. This study provides new insights into the specific clinical features associated with NF1 gene deletions, contributing to better follow-up care for affected patients.

CANCERS (2021)

Article Dermatology

Identification of three clinical neurofibromatosis 1 subtypes: Latent class analysis of a series of 1351 patients

C. Bergqvist, L. Fertitta, K. Ezzedine, A. Jannic, O. Zehou, S. Ferkal, P. Combemale, S. Barbarot, J. Mazereeuw-Hautier, E. Sbidian, P. Wolkenstein

Summary: This study aimed to identify underlying subtypes of NF1 without any prior hypotheses. Through latent class analysis of 1351 NF1 patients, three distinct classes were found: cutaneous neurofibromas class, subcutaneous neurofibromas class, and dysmorphic phenotype class. Patients in different classes showed variations in disease manifestations and complications.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

Article Multidisciplinary Sciences

Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care

Jerome LeGoff, Solen Kerneis, Caroline Elie, Severine Mercier-Delarue, Nabil Gastli, Laure Choupeaux, Jacques Fourgeaud, Marie-Laure Alby, Pierre Quentin, Juliette Pavie, Patricia Brazille, Marie Laure Nere, Marine Minier, Audrey Gabassi, Chrystel Leroy, Beatrice Parfait, Jean-Marc Treluyer, Constance Delaugerre

Summary: The study found that the sensitivity of detecting SARS-CoV-2 RNA in saliva using RT-LAMP is lower compared to nasopharyngeal RT-PCR, saliva RT-PCR, and nasopharyngeal antigen testing. Additionally, the sensitivity of saliva RT-LAMP testing varies significantly based on different reference test criteria.

SCIENTIFIC REPORTS (2021)

Article Allergy

Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders

Julien Rossignol, Amani Ouedrani, Cristina Bulai Livideanu, Stephane Barete, Louis Terriou, David Launay, Richard Lemal, Celine Greco, Laurent Frenzel, Cecile Meni, Christine Bodemere-Skandalis, Laura Polivka, Anne-Florence Collange, Hassiba Hachichi, Sonia Bouzourine, Djazira Nait Messaoud, Mathilde Negretto, Laurence Vendrame, Marguerite Jambou, Marie Gousseff, Stephane Durupt, Jean-Christophe Lega, Jean-Marc Durand, Caroline Gaudy, Gandhi Damaj, Marie-Pierre Gourin, Mohamed Hamidou, Laurence Bouillet, Edwige Le Mouel, Alexandre Maria, Patricia Zunic, Quentin Cabrera, Denis Vincent, Christian Lavigne, Etienne Riviere, Clement Gourguechon, Marie Courbebaisse, David Lebeaux, Beatrice Parfait, Gerard Friedlander, Anne Brignier, Ludovic Lhermitte, Thierry Jo Molina, Julie Bruneau, Julie Agopian, Patrice Dubreuil, Dana Ranta, Alexandre Mania, Michel Arock, Isabelle Staropoli, Olivier Tournilhac, Olivier Lortholary, Olivier Schwartz, Lucienne Chatenoud, Olivier Hermine

Summary: This study investigated the outcomes of patients with cMCAD with COVID-19 and characterized their specific anti-SARS-CoV-2 immune response. The results showed that patients with cMCAD may not be at risk of severe COVID-19, possibly due to their spontaneous production of IFN-gamma.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Article Medical Laboratory Technology

Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial Carcinoma

Guillaume Beinse, Bruno Borghese, Marie Metairie, Pierre-Alexandre Just, Geoffroy Poulet, Simon Garinet, Beatrice Parfait, Audrey Didelot, Camille Bourreau, Natacha Agueeff, Alexandre Lavolle, Benoit Terris, Charles Chapron, Francois Goldwasser, Karen Leroy, Helene Blons, Pierre Laurent-Puig, Valerie Taly, Jerome Alexandre

Summary: This study aimed to identify DNA positions universally hypermethylated in endometrial carcinoma (EC) and develop a digital droplet PCR (ddPCR) assay for detection of hypermethylated circulating tumor DNA (meth-ctDNA) in plasma from EC patients. The study found that methylation of ZSCAN12/OXT can be highly specific and sensitive in detecting ctDNA in plasma, providing promise for personalized approaches for EC patients.

CLINICAL CHEMISTRY (2022)

Letter Biochemistry & Molecular Biology

A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project

Diana Molino, Christine Durier, Anne Radenne, Corinne Desaint, Jacques Ropers, Soizic Courcier, Louis Victorien Vieillard, Claire Rekacewicz, Beatrice Parfait, Victor Appay, Frederic Batteux, Emmanuel Barillot, Michel Cogne, Behazine Combadiere, Christiane S. Eberhardt, Guy Gorochov, Philippe Hupe, Laetitia Ninove, Stephane Paul, Isabelle Pellegrin, Sylvie van der Werf, Maeva Lefebvre, Elisabeth Botelho-Nevers, Inmaculada Ortega-Perez, Marie Jaspard, Samba Sow, Jean Daniel Lelievre, Xavier de Lamballerie, Marie Paule Kieny, Eric Tartour, Odile Launay

NATURE MEDICINE (2022)

Article Genetics & Heredity

Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type

Laurence Pacot, Valerie Pelletier, Albain Chansavang, Audrey Briand-Suleau, Cyril Burin des Roziers, Audrey Coustier, Theodora Maillard, Nicolas Vaucouleur, Lucie Orhant, Cecile Barbance, Alban Lermine, Nadim Hamzaoui, Djihad Hadjadj, Ingrid Laurendeau, Laila El Khattabi, Juliette Nectoux, Michel Vidaud, Beatrice Parfait, Helene Dollfus, Eric Pasmant, Dominique Vidaud

Summary: This case report highlights the importance of whole genome sequencing (WGS) in diagnosing patients with neurofibromatosis type 1 (NF1). WGS can detect structural variants, including copy number variants, that may be missed by other methods. By detecting the pathogenic variant in the cell-free DNA of the patient's pregnant partner, targeted genetic counseling and non-invasive prenatal diagnosis were made possible.

HUMAN GENETICS (2023)

Article Infectious Diseases

One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohort

Paul Loubet, Linda Wittkop, Laetitia Ninove, Mathieu Chalouni, Benoit Barrou, Jean-Yves Blay, Maryvonne Hourmant, Eric Thouvenot, Martine Laville, Bruno Laviolle, Jean-Daniel Lelievre, Jacques Morel, Stephanie Nguyen Quoc, Jean-Philippe Spano, Benjamin Terrier, Anne Thiebaut, Jean-Francois Viallard, Francois Vrtovsnik, Sophie Circosta, Laure Esterle, Axel Levier, Philippe Vanhems, Eric Tartour, Beatrice Parfait, Xavier de Lamballerie, Odile Launay

Summary: This study aimed to investigate the 1-month humoral response to two or three doses of mRNA COVID-19 vaccine in specific populations compared with healthy adults. The results showed a lower humoral response in the specific populations. However, the third dose of the vaccine had a positive effect on the immune response.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Genetics & Heredity

SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicing

Raphael Leman, Beatrice Parfait, Dominique Vidaud, Emmanuelle Girodon, Laurence Pacot, Gerald Le Gac, Chandran Ka, Claude Ferec, Yann Fichou, Celine Quesnelle, Camille Aucouturier, Etienne Muller, Dominique Vaur, Laurent Castera, Flavie Boulouard, Agathe Ricou, Helene Tubeuf, Omar Soukarieh, Pascaline Gaildrat, Florence Riant, Marine Guillaud-Bataille, Sandrine M. Caputo, Virginie Caux-Moncoutier, Nadia Boutry-Kryza, Francoise Bonnet-Dorion, Ines Schultz, Maria Rossing, Olivier Quenez, Louis Goldenberg, Valentin Harter, Michael T. Parsons, Amanda B. Spurdle, Thierry Frebourg, Alexandra Martins, Claude Houdayer, Sophie Krieger

Summary: This article introduces a splicing prediction pipeline called SPiP, which comprehensively assesses the impact of variants on different splicing motifs using a machine learning approach. The results show that SPiP has high sensitivity and specificity, and can effectively detect spliceogenic variants.

HUMAN MUTATION (2022)

Article Clinical Neurology

Surgical Management of Peripheral Nerve Pathology in Patients With Neurofibromatosis Type 2

Matthieu Peyre, Suzanne Tran, Beatrice Parfait, Isabelle Bernat, Franck Bielle, Michel Kalamarides

Summary: Neurofibromatosis type 2 (NF2) is a rare genetic disorder characterized by central nervous system lesions, but it can also lead to peripheral nerve pathology causing pain and sensory loss. This study investigated the tumor burden of peripheral nerve pathology in NF2 patients and found that surgery is a safe and effective method for treating peripheral nerve schwannomas-associated pain in NF2, except for rare multinodular tumors.

NEUROSURGERY (2023)

Article Multidisciplinary Sciences

Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years

Christine Durier, Laetitia Ninove, Maeva Lefebvre, Anne Radenne, Corinne Desaint, Jacques Ropers, Rebecca Bauer, Said Lebbah, Diane Carette, Marie Lachatre, Anne-Sophie Lecompte, Dominique Deplanque, Elisabeth Botelho-Nevers, Anne Conrad, Bertrand Dussol, Zoha Maakaroun-Vermesse, Giovanna Melica, Jean-Francois Nicolas, Renaud Verdon, Jacques Kiladjian, Paul Loubet, Catherine Schmidt-Mutter, Christian Duale, Severine Ansart, Stephane Priet, Axel Levier, Diana Molino, Louis-Victorien Vieillard, Beatrice Parfait, Jean-Daniel Lelievre, Eric Tartour, Xavier de Lamballerie, Odile Launay

Summary: The immune response generated by a COVID-19 vaccine booster against delta and omicron variants was evaluated in 65 adults (aged 65-84) shortly after receiving the first booster dose. The study showed an increase in SARS-CoV-2 neutralizing antibodies in individuals who had not been previously infected, regardless of age, while a smaller increase was observed in those who had been infected before receiving a single dose of the primary vaccine. It is important to note that the humoral response was only observed starting from the 5th day after the booster dose.

SCIENTIFIC REPORTS (2022)

No Data Available